| [1] |
Singh R, Kishore L, Kaur N. Diabetic peripheral neuropathy: current perspective and future directions[J]. Pharmacol Res, 2014, 80: 21-35.
|
| [2] |
Faruque LI, Wiebe N, Ehteshami-Afshar A, et al. Effect of telemedicine on glycated hemoglobin in diabetes: a systematic review and meta-analysis of randomized trials[J]. CMAJ, 2017, 189(9): E341-E364.
|
| [3] |
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华糖尿病杂志，2021, 13(4): 315-409.
|
| [4] |
Apelqvist J, Bakker K, van Houtum WH, et al. International consensus and practical guidelines on the management and prevention of the diabetic foot. International Working Group on the Diabetic Food[J]. Diabetes Metab Res Rev, 2000, 16 Suppl 1: S84-92.
|
| [5] |
Marston WA. Risk factors associated with healing chronic diabetic foot ulcers: the importance of hyperglycemia[J]. Ostomy Wound Manage, 2006, 52(3): 26-28, 30, 32 passim.
|
| [6] |
Yekta Z, Pourali R, Nezhadrahim R, et al. Clinical and behavioral factors associated with management outcome in hospitalized patients with diabetic foot ulcer[J]. Diabetes Metab Syndr Obes, 2011, 4: 371-375.
|
| [7] |
Miyajima S, Shirai A, Yamamoto S, et al. Risk factors for major limb amputations in diabetic foot gangrene patients[J]. Diabetes Res Clin Pract, 2006, 71(3): 272-279.
|
| [8] |
Atkins D, Briss PA, Eccles M, et al. Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system[J]. BMC Health Serv Res, 2005, 5(1): 25.
|
| [9] |
医政医管局. 国家卫生健康委办公厅关于加强体表慢性难愈合创面(溃疡)诊疗管理工作的通知[EB/OL]. (2019-12-2)[2022-12-1].
URL
|
| [10] |
Eggert JV, Worth ER, Van Gils CC. Cost and mortality data of a regional limb salvage and hyperbaric medicine profram for Wagner grade 3 or 4 diabetic foot ulcers[J]. Undersea Hyperb Med, 2016, 43(1): 1-8.
|
| [11] |
Wagner FW Jr. The dysvascular foot: a system for diagnosis and treatment[J]. Foot Ankle, 1981, 2(2): 64-122.
|
| [12] |
Monteiro-Soares M, Boyko EJ, Ribeiro J, et al. Predictive factors for diabetic foot ulceration: a systematic review[J]. Diabetes Metab Res Rev, 2012, 28(7): 574-600.
|
| [13] |
管珩，刘志民，李光伟，等. 50岁以上糖尿病人群周围动脉闭塞性疾病相关因素分析[J]. 中华医学杂志，2007, 87(1): 23-27.
|
| [14] |
Hinchliffe RJ, Brownrigg JR, Apelqvist J, et al. IWGDF guidance on the diagnosis, prognosis and management of peripheral artery disease in patients with foot ulcers in diabetes[J]. Diabetes Metab Res Rev, 2016, 32 Suppl 1: 37-44.
|
| [15] |
Gerhard-Herman MD, Gornik HL, Barrett C, et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[J]. Circulation, 2017, 135(12): e726-e779.
|
| [16] |
Aboyans V, Criqui MH, Abraham P, et al. Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association[J]. Circulation, 2012, 126(24): 2890-2909.
|
| [17] |
Lipsky BA, Berendt AR, Cornia PB, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections[J]. Clin Infect Dis, 2012, 54(12): e132-173.
|
| [18] |
Lavery LA, Ryan EC, Ahn J, et al. The infected diabetic foot: re-evaluating the Infectious Diseases Society of America Diabetic Foot Infection Classification[J]. Clin Infect Dis, 2020, 70(8): 1573-1579.
|
| [19] |
Lee WS, Kim J. Diabetic cardiomyopathy: where we are and where we are going[J]. Korean J Intern Med, 2017, 32(3): 404-421.
|
| [20] |
Sumpio BE. Contemporary evaluation and management of the diabetic foot[J]. Scientifica (Cairo), 2012, 2012: 435487.
|
| [21] |
Raspovic KM, Ahn J, La Fontaine J, et al. End-stage renaldisease negatively affects physical quality of life in patients with diabetic foot complications[J]. Int J Low Extrem Wounds, 2017, 16(2): 135-142.
|
| [22] |
Brownrigg JR, Hinchliffe RJ, Apelqvist J, et al. Performance of prognostic markers in the prediction of wound healing or amputation among patients with foot ulcers in diabetes: a systematic review[J]. Diabetes Metab Res Rev, 2016, 32 Suppl 1: 128-135.
|
| [23] |
Acín F, Varela C, López de Maturana I, et al. Results of infrapopliteal endovascular procedures performed in diabetic patients with critical limb ischemia and tissue loss from the perspective of an angiosome-oriented revascularization strategy[J]. Int J Vasc Med, 2014, 2014: 270539.
|
| [24] |
Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes[J]. JAMA, 2005, 293(2): 217-228.
|
| [25] |
Driver VR, Madsen J, Goodman RA. Reducing amputation rates in patients with diabetes at a military medical center: the limb preservation service model[J]. Diabetes Care, 2005, 28(2): 248-253.
|
| [26] |
Carls GS, Gibson TB, Driver VR, et al. The economic value of specialized lower-extremity medical care by podiatric physicians in the treatment of diabetic foot ulcers[J]. J Am Podiatr Med Assoc, 2011, 101(2): 93-115.
|
| [27] |
Krishnan S, Nash F, Baker N, et al. Reduction in diabetic amputations over 11 years in a defined U. K. population: benefits of multidisciplinary team work and continuous prospective audit[J]. Diabetes Care, 2008, 31(1): 99-101.
|
| [28] |
Anichini R, Zecchini F, Cerretini I, et al. Improvement of diabetic foot care after the Implementation of the International Consensus on the Diabetic Foot (ICDF): results of a 5-year prospective study[J]. Diabetes Res Clin Pract, 2007, 75(2): 153-158.
|
| [29] |
Nather A, Siok Bee C, Keng Lin W, et al. Value of team approach combined with clinical pathway for diabetic foot problems: a clinical evaluation[J]. Diabet Foot Ankle, 2010, 1.
|
| [30] |
Wang C, Mai L, Yang C, et al. Reducing major lower extremity amputations after the introduction of a multidisciplinary team in patient with diabetes foot ulcer[J]. BMC Endocr Disord, 2016, 16(1): 38.
|
| [31] |
Christman AL, Selvin E, Margolis DJ, et al. Hemoglobin A1c predicts healing rate in diabetic wounds[J]. J Invest Dermatol, 2011, 131(10): 2121-2127.
|
| [32] |
Markuson M, Hanson D, Anderson J, et al. The relationship between hemoglobin A(1c) values and healing time for lower extremity ulcers in individuals with diabetes[J]. Adv Skin Wound Care, 2009, 22(8): 365-372.
|
| [33] |
Hasan R, Firwana B, Elraiyah T, et al. A systematic review and meta-analysis of glycemic control for the prevention of diabetic foot syndrome[J]. J Vasc Surg, 2016, 63(2 Suppl): 22S-28S.e1-2.
|
| [34] |
Chen Z, Liao W, Hu S, et al. Application of percutaneous oxygen partial pressure in determining amputation plane of diabetic foot[J]. Minerva Med, 2022.
|
| [35] |
Widatalla AH, Mahadi SE, Shawer MA, et al. Diabetic foot infections with osteomyelitis: efficacy of combined surgical and medical treatment[J]. Diabet Foot Ankle, 2012, 3.
|
| [36] |
Wieman TJ, Mercke YK, Cerrito PB, et al. Resection of the metatarsal head for diabetic foot ulcers[J]. Am J Surg, 1998, 176(5): 436-441.
|
| [37] |
Janis JE, Kwon RK, Attinger CE. The new reconstructive ladder: modifications to the traditional model[J]. Plast Reconstr Surg, 2011, 127 Suppl 1: 205S-212S.
|
| [38] |
Noble-Bell G, Forbes A. A systematic review of the effectiveness of negative pressure wound therapy in the management of diabetes foot ulcers[J]. Int Wound J, 2008, 5(2): 233-242.
|
| [39] |
Gregor S, Maegele M, Sauerland S, et al. Negative pressure wound therapy: a vacuum of evidence？[J]. Arch Surg, 2008, 143(2): 189-196.
|
| [40] |
Jiang Y, Ran X, Jia L, et al. Epidemiology of type 2 diabetic foot problems and predictive factors for amputation in China[J]. Int J Low Extrem Wounds, 2015, 14(1): 19-27.
|
| [41] |
Hocking G, Mitchell CH. Optimizing the safety and practice of ultrasound-guided regional anesthesia: the role of echogenic technology[J]. Curr Opin Anaesthesiol, 2012, 25(5): 603-609.
|
| [42] |
Lai HY, Foo LL, Lim SM, et al. The hemodynamic and pain impact of peripheral nerve block versus spinal anesthesia in diabetic patients undergoing diabetic foot surgery[J]. Clin Auton Res, 2020, 30(1): 53-60.
|
| [43] |
Choi YS, Shin HJ, Park JY, et al. Ultrasound-guided femoral and popliteal sciatic nerve blocks for below knee surgery in patients with severe cardiac disease[J]. Korean J Anesthesiol, 2015, 68(5): 513-515.
|
| [44] |
Kim NY, Lee KY, Bai SJ, et al. Comparison of the effects of remifentanil-based general anesthesia and popliteal nerve block on postoperative pain and hemodynamic stability in diabetic patients undergoing distal foot amputation: a retrospective observational study[J]. Medicine (Baltimore), 2016, 95(29): e4302.
|
| [45] |
Lipsky BA, Senneville é，Abbas ZG, et al. Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update)[J]. Diabetes Metab Res Rev, 2020, 36 Suppl 1: e3280.
|
| [46] |
Johnson SW, Drew RH, May DB. How long to treat with antibiotics following amputation in patients with diabetic foot infections? Are the 2012 IDSA DFI guidelines reasonable？[J]. J Clin Pharm Ther, 2013, 38(2): 85-88.
|
| [47] |
Falanga V. Classifications for wound bed preparation and stimulation of chronic wounds[J]. Wound Repair Regen, 2000, 8(5): 347-352.
|
| [48] |
Schultz GS, Sibbald RG, Falanga V, et al. Wound bed preparation: a systematic approach to wound management[J]. Wound Repair Regen, 2003, 11 Suppl 1: S1-28.
|
| [49] |
徐媛，刘宏伟. 创面修复"TIME"原则及其意义[J]. 中国组织工程研究，2012, 16(11): 2059-2062.
|
| [50] |
Steed DL, Attinger C, Colaizzi T, et al. Guidelines for the treatment of diabetic ulcers[J]. Wound Repair Regen, 2006, 14(6): 680-692.
|
| [51] |
Elgzyri T, Larsson J, Nyberg P, et al. Early revascularization after admittance to a diabetic foot center affects the healing probability of ischemic foot ulcer in patients with diabetes[J]. Eur J Vasc Endovasc Surg, 2014, 48(4): 440-446.
|
| [52] |
Armstrong DG, Kanda VA, Lavery LA, et al. Mind the gap: disparity between research funding and costs of care for diabetic foot ulcers[J]. Diabetes Care, 2013, 36(7): 1815-1817.
|
| [53] |
Elgzyri T, Larsson J, Törne J, et al. Outcome of ischemic foot ulcer in diabetic patients who had no invasive vascular intervention[J]. Eur J Vasc Endovasc Surg, 2013, 46(1): 110-117.
|